Clark Street Value sold 2/3rds of its position in Avenue Therapeutics Inc. (NASDAQ:ATXI) stock. Clark Street Value is an individual investor that is focused on finding value and special situation investments. Avenue Therapeutics Inc. (NASDAQ:ATXI) is a pharmaceutical company. In the last one year, Avenue Therapeutics Inc. (NASDAQ:ATXI) stock lost 31.1% and on January 5th it had a closing price of $6.14.
Clark Street Value sold 2/3rds of its position in Avenue Therapeutics Inc. (NASDAQ:ATXI)...